Matrix metalloproteinase-7 (MMP-7)

Links to databases

 

Extracellular matrix-degrading proteinases are upregulated in atherosclerotic lesions and can contribute to subsequent pathological events. Can be regarded as risk factors, and thus as potential biomarkers for incident CVD.

Sample type

Analytical Measuring Range

    • LOD (pg/mL)
    • 7.63
    • LLOQ (pg/mL)
    • 7.63
    • ULOQ (pg/mL)
    • 31250
    • Hook (pg/mL)
    • 62500
    • Range (logs)
    • 3.6

Calibrator curve for validation data (generated in multiplex)

Matrix metalloproteinase-7 (MMP-7)

Precision

    • Within run precision Coefficient of Variation (CV)
    • 9%
    • Between run precision Coefficient of Variation (CV)
    • 9%

Precision (repeatability) is calculated from linearized NPX values over LOD.

Biomarker Validation Data

Additional validation data, as well as a more detailed description of how the Olink panels are quality controlled can be found in our Data Validation documents. To download or to learn more go to the Data Validation page.

View all CVD II panel biomarkers >

View all biomarkers >